COMP <GO>
VCYT vs CDNA // FORWARD P/E MULTIPLE
Veracyte Inc. (NASDAQ) VS. CareDx Inc. (NASDAQ) • 15-METRIC TALLY: VCYT 8
— CDNA 3
▲ FORWARD P/E MULTIPLE LEADER: CDNA
LAST: $50.01 (-4.14%) • MKT CAP: $4.02B
forward-pe
53.1x
LAST: $87.41 (+22.22%) • MKT CAP: $4.59B
forward-pe
21.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VCYT VS. CDNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VCYT | CDNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.60% | -8.20% | +12.80 | VCYT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 58.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.02% | 0.67% | +2.35 | VCYT | /fcf-yield <GO> |
| Operating Margin | 11.20% | -8.10% | +19.30 | VCYT | /operating-margins <GO> |
| Net Profit Margin | 12.80% | -5.60% | +18.40 | VCYT | /net-margins <GO> |
| Revenue Growth (YoY) | 16.00% | 13.80% | +2.20 | VCYT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 19.22 | +6.78 | VCYT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | VCYT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.7 | 67.4 | -9.70 | CDNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.06 | +0.02 | VCYT | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 53.1x | 21.0x | +32.10 | CDNA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.02B | $4.59B | -$572.4M | CDNA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VCYT REV | CDNA REV | VCYT GROSS % | CDNA GROSS % | VCYT FCF | CDNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $517.1M | $379.8M | 70.1% | — | $126.6M | $24.9M |
| FY 2024 | $445.8M | $333.8M | 66.9% | — | $63.8M | $23.0M |
| FY 2023 | $361.1M | $280.3M | — | — | $28.0M | -$31.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VCYT // BETA 1.08
CDNA // BETA 1.06